Invacare Profit Margin 2006-2019 | IVC

Current and historical gross margin, operating margin and net profit margin for Invacare (IVC) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Invacare net profit margin as of March 31, 2019 is -4.56%.
Invacare Annual Profit Margins
Invacare Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.163B $0.972B
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $66.953B 22.30
McKesson (MCK) United States $24.565B 9.70
Align Technology (ALGN) United States $22.083B 59.62
AmerisourceBergen (ABC) United States $17.714B 12.58
Laboratory Of America Holdings (LH) United States $16.687B 15.60
Cooper (COO) United States $16.330B 28.23
Cardinal Health (CAH) United States $13.636B 8.83
DENTSPLY SIRONA (XRAY) United States $13.545B 28.24
Henry Schein (HSIC) United States $10.334B 17.37
West Pharmaceutical Services (WST) United States $9.008B 41.84
Merit Medical Systems (MMSI) United States $3.237B 33.63
CONMED (CNMD) United States $2.402B 38.32
Patterson (PDCO) United States $2.303B 18.19
Atrion (ATRI) United States $1.616B 46.14
STAAR Surgical (STAA) United States $1.301B 88.67
Antares Pharma (ATRS) United States $0.511B 0.00
Lifevantage (LFVN) United States $0.161B 21.32
Endologix (ELGX) United States $0.132B 0.00
Pro-Dex (PDEX) United States $0.052B 15.96
Biolase (BIOL) United States $0.031B 0.00
Retractable Technologies (RVP) United States $0.024B 0.00
Milestone Scientific (MLSS) United States $0.014B 0.00